Because there aren’t treatment options available for the management of progressive multiple sclerosis (MS), Patricia K. Coyle, MD, explains the challenges clinicians are faced with when treating patients who transition into a progressive stage of the disease.
Dr Coyle and Leslie Fish, PharmD, explain that although the topic of when to end therapy for patients who transition into a worsening stage is controversial, it is necessary to make personalized treatment decisions.
Dr Fish further explains how the rising costs of agents for the treatment MS further complicate management of MS and affect a clinician’s decision about when to begin or end therapy for a patient.
Episode 13 - Treatment Challenges for Progressive Disease
During this segment, Patricia K. Coyle, MD, and Leslie Fish, PharmD, raise concerns about treating patients who transition into a progressive phase of multiple sclerosis.
Published Online: January 03, 2014